Status:
COMPLETED
Sentinel Node in Larynx and Pharynx Cancers
Lead Sponsor:
Radboud University Medical Center
Conditions:
Head and Neck Cancer
Lymph Node Metastases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study explores the feasibility of sentinel lymph node identification in pharynx and larynx cancers using flexible endoscopy-guided tracer injection.
Detailed Description
The presence of lymph node metastases has a large impact on prognosis and treatment in head-and neck cancer (HNC) patients and necessitates treatment intensification. However, despite increased spatia...
Eligibility Criteria
Inclusion
- Male or female aged \>18 years.
- Mucosal tumor of the oropharynx, hypopharynx or larynx.
- Patients planned to undergo biopsy via flexible endoscopy.
- Patients planned to undergo curative radiotherapy with or without concurrent chemotherapy.
- Patient provided written informed consent.
Exclusion
- Patients who underwent previous surgery or radiotherapy to the neck.
- Patients with airway obstruction causing stridor.
- Prior allergic reaction to Tc-99m-nanocolloïd.
- Pregnancy.
- Unable to provide informed consent.
Key Trial Info
Start Date :
March 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 11 2022
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT04068636
Start Date
March 9 2020
End Date
January 11 2022
Last Update
April 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboudumc
Nijmegen, Gelderland, Netherlands, 6500 HB